Combating Healthcare-Acquired Infections (HAIs) with Syndromic Infectious Disease Testing

Healthcare-acquired infections (HAIs) pose a serious threat to patient health and safety. The U.S. Centers for Disease Control and Prevention (CDC) has reported that nearly 1 in 17 patients die due to an HAI-related infection each year.1

Many HAIs are caused by some of the most dangerous antimicrobial-resistant organisms, such as carbapenem-resistant Acinetobacter baumanii and Candida auris, which can increase the likelihood of sepsis and death.2 In the interest of patient safety and public health, a swift, accurate diagnosis should be made as soon as possible to help define the right course of treatment. Infection prevention practices, early detection, and infection surveillance can all help mitigate the risk of HAIs and minimize the spread of antibiotic-resistant bacteria.